Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer
6 affiliations
- 1Dana-Farber Cancer Institute, Boston, MA, USA
- 22Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 3Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
- 41Dana-Farber Cancer Institute, Boston, MA, USA
- 57Dana-Farber Cancer Institute, Boston, MA, USA
- 6University of Michigan, Ann Arbor, MI, USA
Related
- Co-targeting KRAS and BCL-2 induces pyroptosis and antitumor tertiary lymphoid structures
- Synergistic antitumor effects of combined pembrolizumab and anlotinib via EGFR inhibition and tumor microenvironment remodeling in high-grade serous ovarian cancer
- c-MET Inhibition Is Accompanied by PD-L1 Upregulation and Immunosuppression-Related Tumor Microenvironment Changes in Esophageal Squamous Cell Carcinoma, With Enhanced Antitumor Activity in Combination With Anti-PD-1 Therapy.
- Melatonin Mitigates Doxorubicin‐Induced Cardiotoxicity by Targeting the USP18/PKM2 Axis Without Compromising Antitumor Efficacy
- In vitro synergistic antifungal activity of silybin-posaconazole combination against Candida auris
BibTeX
@article{romee2026cart,
title = {{318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer}},
author = {Rizwan Romee and David Barbie and Eden Bobilev and Mubin Tarannum and Marco Campisi and Alan E Bers and Ian Gillanders and Navin R Mahadevan},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0318},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0318},
note = {CC BY},
}
RIS
TY - JOUR
TI - 318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer
AU - Rizwan Romee
AU - David Barbie
AU - Eden Bobilev
AU - Mubin Tarannum
AU - Marco Campisi
AU - Alan E Bers
AU - Ian Gillanders
AU - Navin R Mahadevan
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0318
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0318
SN - 2051-1426
ER -